Using plasma exchange to successfully manage thyrotoxicosis in a patient with possible antithyroid drug-related thrombotic thrombocytopenic purpura

Creative Commons License

TAZEGÜL G., ÖĞÜT T. S., Bozoglan H., DOĞAN Ö., YILMAZ N., Ulas T., ...More

Endocrine Regulations, vol.51, no.3, pp.153-156, 2017 (Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: 51 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.1515/enr-2017-0016
  • Journal Name: Endocrine Regulations
  • Journal Indexes: Scopus
  • Page Numbers: pp.153-156
  • Keywords: Methimazole, Plasma exchange, Thrombotic thrombocytopenic purpura, Thyrotoxicosis, Toxic multinodular goiter
  • Open Archive Collection: AVESIS Open Access Collection
  • Marmara University Affiliated: No

Abstract

© 2017, De Gruyter Open Ltd. All rights reserved.Objective. Thrombotic thrombocytopenic purpura (TTP) is a rare disease characterized by microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic abnormalities, fever, and renal insufficiency. The association or co-existence of thyrotoxicosis or antithyroid drugs with TTP has not been previously reported. Subject and Results. Herein, we present a 54-year-old female patient newly diagnosed with toxic multinodular goiter accompanying with TTP, possibly triggered by either thyrotoxicosis or antithyroid drugs. Conclusions. The present report is the first in the literature to demonstrate the co-existence of these two diseases and the use of plasma exchange as a modality to treat both conditions.